They point out that the medicine’s antiviral effect on coronaviruses was only proven in the Petri dish. Clinical studies are still needed, noted the authors on Monday.
In September, Thurgau-based manufacturer A. Vogel and Spiez Laboratory published a study about the natural healing properties of Echinaforce, a drug made with the herb echinacea. They reported that the drug was able to kill coronaviruses in a test tube. Demand and sales reportedly went up.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
This month the authors have issued a correction in the specialist journal VirologyExternal link. According to the study, the product needs direct contact with virus particles in order to have a virus-killing effect. Because Echinaforce is taken orally, it is unclear how it would work, which is why the authors say clinical studies in humans are needed.
Echinaforce preparations are herbal medicines intended for people who are prone to colds.
More
More
Swiss factory rushes to prepare for Moderna Covid-19 vaccine
This content was published on
Workers are racing to set up production lines at the Lonza factory in Visp to be able to start making a vaccine for US firm Moderna later this year.
Alternative medicine no longer an ‘outsider’ in Switzerland’s health system
This content was published on
Once on the margins of the healthcare system, growing public demand for complementary medicine has led to increased regulation.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Planned solar park at Bern airport scaled back after talks
This content was published on
The ground-mounted plant at Belpmoos Airport outside the Swiss capital will be smaller than originally planned, the parties involved said on Tuesday.
Legal action filed against Swiss purchase of Israeli drones
This content was published on
Legal action aims to put an end to the delivery of the six Elbit reconnaissance drones already plagued by delays and setbacks.
Higher direct payments fail to curb scrub encroachment on alpine pastures
This content was published on
The scrub encroachment on Swiss alpine pastures leads to the loss of grassland and damages the typical landscape. It is also responsible for the decline in biodiversity. Despite higher direct payments, the bushes continue to spread.
Head of Swiss financial regulator’s Banks division quits
This content was published on
Thomas Hirschi, head of the Banks division of the Swiss Financial Market Supervisory Authority FINMA will leave at the end of August.
Swiss population satisfied with life according to survey
This content was published on
In a survey, the population of German-speaking and French-speaking Switzerland expressed general satisfaction with their lives. Respondents were less happy with politics and their personal finances, according to the online comparison service Moneyland.
WHO ‘extremely concerned’ about growing vaccination scepticism
This content was published on
According to the World Health Organisation (WHO), vaccination scepticism and a collapse in funding for vaccination campaigns pose a major threat to the health of the world's population.
High-net-worth individuals prioritise well-being over material possessions
This content was published on
The priorities of wealthy private individuals have shifted against the backdrop of ongoing geopolitical tensions and trade disputes. While spending on luxury goods is declining, demand for travel and experiences is unabated.
Join the conversation!